Merck

Merck is one of the old-line pharmaceutical names in the US, tied to prescription drugs, vaccines, and the long, expensive work of turning lab results into treatments. By our assessment, it is strongest when a reader cares about serious drug development and the scale that comes with it: research, regulation, manufacturing, and global distribution. The trade-off is familiar to this kind of company — slow cycles, patent pressure, and a business that depends on approvals rather than quick wins. In practice that means a conservative, heavily managed operation rather than a flashy consumer brand, with most of the action happening far from the shelf. Compared with smaller biotech firms, Merck sits on the large, settled end of the field. It is a name for people who want a big pharmaceutical house, not a nimble startup.